Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Depot tetracosactide
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 83 💬
2TETRACOSACTIDE
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 83, 113, 145, 222 💬
3Tetracosactide Acetate
(D02105)
[2] Acetate,
Tetracosactide
[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 83, 145 💬
4TETRACOSACTIDE ESACETATO
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113 💬
5TETRACOSACTIDE HEXAACETATE
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113 💬
6Tetracosactide hexacetaat
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 222 💬